NLX-101 (F15599) is under development for the treatment of Rett syndrome and depression. The drug candidate is administered by oral route. The drug candidate is a new chemical entity (NCE). The drug ...

Discover the truth in our NeuroQuiet reviews – does this hearing support supplement really deliver on its promises, or is it ...